Target‐Engagement Prediction From Molecular Structure, In Vitro and Animal Data: A Tutorial for Early Assessment of Clinical Drug Exposure and Therapeutic/Adverse Potential Using the ANDROMEDA and PLATO Software on the InSilicoTrials Platform [PDF]
ABSTRACT The target‐engagement predictor, implemented within the InSilicoTrials cloud‐based, AI‐powered platform for model‐informed drug discovery and development, enables early exploration of time‐dependent pharmacological responses. Predictions can be generated using inputs ranging from molecular structure to in vitro, animal, and clinical data ...
Totis N +15 more
europepmc +2 more sources
Low-intensity pulsed ultrasound-mediated nose-to-brain co-delivery of β-blockers and aPD-L1 enhances glioblastoma immunotherapy. [PDF]
Dong L +20 more
europepmc +1 more source
β -Blockers in Hemodialysis : Does Dialyzability Matter? [PDF]
Moloney BM, Mc Causland FR.
europepmc +1 more source
International survey on the management of portal hypertension. [PDF]
Bashiri K +4 more
europepmc +1 more source
Bradycardia-Dependent Loss of Atrial Capture After Single-Chamber Leadless Atrial Pacemaker Implantation. [PDF]
Soderstrom MA +5 more
europepmc +1 more source
Sugar-Based Eutectic Systems Combined with Cyclodextrins for Enhanced Solubility of Carvedilol. [PDF]
Polo A +4 more
europepmc +1 more source
Cancer Therapeutics-Related Cardiac Toxicity and Heart Failure: Current Evidence and Unresolved Challenges. [PDF]
Park H, Lee N, Park SM.
europepmc +1 more source
Prognostic Impact of Carvedilol vs. Metoprolol on Long-Term Outcomes in Patients with Heart Failure and Mildly Reduced Ejection Fraction. [PDF]
Weidner K +10 more
europepmc +1 more source
Editorial: Non-Selective Beta-Blockers in Decompensated Cirrhosis-More Friends Than Foes. [PDF]
Gagliardi R, Berzigotti A.
europepmc +1 more source

